1140517-89-0

Upstream product

• 72784-47-5 ethyl 1-aminocyclopropane-1-carboxylate 
• 122-01-0 4-chloro-benzoyl chloride 
• 74-11-3 para-chlorobenzoic acid 

Downstream Products

• 1140517-90-3 1-[(4-chlorobenzoyl)amino]cyclopropanecarboxylic acid 
• 1310816-21-7 4-Chloro-N-[1-[[(4R)-5,6-dihydro-4H-imidazo[1,2-a][1]benzazepin-4-yl]carbamoyl]cyclopropyl]benzamide 
• 1310816-82-0 4-chloro-N-[1-[[(4R)-5,6-dihydro-4H-imidazo[1,2-a][1]benzazepin-4-yl]carbamoyl]cyclopropyl]benzamide 4-methylbenzenesulfonic acid salt 
• 1310816-87-5 4-chloro-N-[1-[[(4R)-5,6-dihydro-4H-imidazo[1,2-a][1]benzazepin-4-yl]carbamoyl]cyclopropyl]benzamide hydrochloride 

Relevant academic research and scientific papers

Inhibitors of Diacylglycerol Acyltransferase

This invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof; as well as a method for treating obesity, a method for treating diabetes, and a pharmaceutical composition.

PROTEASOME INHIBITORS

The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.

Proteasome inhibitors

The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.